The role of antibiotics in the treatment of infectious diarrhea

Gastroenterology Clinics of North America

Volumn 30, Issue 3, 2001, Pages 817-835

  Oldfield III, Edward C ^a   Wallace, Mark R ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; QUINOLONE DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; ESCHERICHIA COLI; HEALTH CARE COST; HUMAN; IMMUNE DEFICIENCY; LIVER CIRRHOSIS; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; SHIGELLA; TREATMENT PLANNING; VIBRIO CHOLERAE;

EID: 0034833837     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8553(05)70212-0     Document Type: Review

References (149)

1. Trends in bacterial resistance to fluoroquinolones
2. Treatment of typhoid fever: Randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol
3. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: A randomized double-blind clinical trial
4. Campylobacter jejuni and the expanding spectrum of related infections
5. Clostridium difficile infection associated with antineoplastic chemotherapy: A review
6. Multidrug resistance in Vibrio cholerae
7. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis
8. β-Lactam resistance in Aeromonas spp. caused by inducible β-lactamases active against penicillins, cephalosporins, and carbapenems
9. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections
10. Potentially lethal complications of shigellosis
11. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid
12. The magnitude of the global problem of diarrhoeal disease: A ten-year update
13. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India
14. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone
15. Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk
16. Epidemiology of traveler's diarrhea and relative importance of various pathogens
17. Campylobacter enteritis in Denver
18. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding
19. Escherichia coli O157:H7 and the hemolytic-uremic syndrome
20. Quinolone arthropathy in animals versus children
21. Yersinia enterocolitica infections in hospitalized patients: The problem of hospital-acquired infections
22. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home
23. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome
24. In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-β-lacatamase-inhibitor combinations
25. Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli
26. Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT 104 infections linked to raw-milk cheese in northern California
27. Yersinia enterocolitica and Yersinia pseudotuberculosis
28. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae 0139 infection: Comparison with V. cholerae 01 infection
29. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin
30. Oral bacitracin vs vancomycin therapy for Clostridium dlfficile-induced diarrhea
31. Treatment of traveler's diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone
32. Five versus three days of ofloxacin therapy for traveler's diarrhea: A placebo-controlled study
33. Efficacy of norfloxacin and doxycycline for treatment of Vibrio cholerae 0139 infection
34. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine
35. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea
36. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler's diarrhea
37. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis
38. Antimicrobial susceptibilities of halophilic vibrios
39. Antibiotic treatment of Yersinia enterocolitica septicemia: A retrospective review of 43 cases
40. One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi
41. Aeromonas-related diarrhea in adults
42. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children
43. Infections diarrhea
44. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults
45. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults
46. Aeromonas-associated gastroenteritis
47. Focal infections due to non-typi Salmonella in patients with AIDS: Report of 10 cases and review
48. Emerging quinolone-resistant Salmonella in the United States
49. Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children
50. Emerging quinolone-resistant Salmonella in the United States
51. Ceftriaxone-resistant Salmonella in the United States
52. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone
53. Mechanism and management of antibiotic-associated diarrhea
54. Aeromonas intestinal infections in the United States
55. Plesiomonas enteric infections in the United States
56. Antibiotics in Yersinia enterecolitica infections
57. Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones
58. Evolving concepts regarding the genus Aeromonas: An expanding panorama of species, disease presentations, and unanswered questions
59. Drug-induced Clostridium difficile-associated disease
60. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metconidazole
61. Back to basics in management of Clostridium difficile infections
62. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children
63. Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea
64. Antimicrobial susceptibility of Plesiomonas shigelluides from patients with diarrhea
65. Antibiotic therapy for Salmonella enteritis
66. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of shiga-like toxin producing strains by colony blot assay
67. Clostridium difficile colitis
68. Randomized controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139
69. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin
70. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan
71. In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents
72. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent
73. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis difficile-associated diarrhea
74. Campylobacter infections
75. Bacteremia due to non-typhi Salmonella: Analysis of 64 cases and review
76. Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic
77. Vibrio infections on the Gulf Coast: Results of first year of regional surveillance
78. Escherichia coli O157:H7, an emerging gastrointestinal pathogen: Results of a one-year, prospective, population-based study
79. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
80. Double-blind placebo-controlled trial of erythromycin in the treatment of clinical Campylobacter infection
81. Yersinia enterocolitica gastroenteritis: A prospective study of clinical, bacteriologic, and epidemiologic features
82. Quinolone resistance from a transferable plasmid
83. Short-term treatment of traveler's diarrhea with norfloxacin: A double-blind, placebo-controlled study during two seasons
84. Seasonal variation in etiology of traveler's diarrhea
85. Escherichia coli O157:H7
86. Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: Clinical aspects and a controlled trial of tetracycline
87. Sahnonella species, including Salmonella typhi
88. An outbreak of multidrug-resistant, quinolone resistant Salmonella enterica serotype typhimurium DTI04
89. Comparison of the efficacy of tetracycline and norfloxacin in the treatment of acute severe watery diarrhea
90. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents
91. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents
92. Ciprofloxacin and loperamide in the treatment of bacillary dysentery
93. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents
94. Clinical features of sporadic Yersinia enterocolitica infections in Norway
95. Infections with Escherichia coil O157:H7 in Washington State, the first year of statewide disease surveillance
96. Erythromycin in treatment of Campylobacter enteritis in children
97. Placebo controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis
98. Hemolytic-uremic syndrome during an outbreak of Escherichia coil O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations
99. Treatment of traveler's diarrhea with ciprofloxacin and loperamide
100. Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica
101. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea
102. Bacteremia due to Campylobacter species: Clinical findings and antimicrobial susceptibility patterns
103. Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Eschenchia coli disease
104. Antibmicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990
105. Randomized, controlled trial of antibiotic therapy for Escherichia colt O157:H7 enteritis
106. The search for a better oral rehydration solution for cholera
107. Efficacy of a single dose of furazolidone for treatment of cholera in children
108. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS
109. Epidemic Shigella dysenterine type 1 in Burundi: Panresistance and implications for prevention
110. Treatment of Campylobacter-associated enteritis with erythromycin
111. A clinicapathologic study of entermyte-adherent Escherirhia coli: A cause of protracted diarrhea in infants
112. Multidrug-resistant Salmonella typhi: A worldwide epidemic
113. A randomized clinical trial to compare efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children
114. Escherichia col O157:H7 diarrhea in a nursing home: Clinical, epidemiological, and pathological findings
115. Antimicrobial resistance in organisms causing diarrheal disease
116. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998
117. Randomized trial of single-dose ciprofloxacin for travelers' diarrhorea
118. Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults
119. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children
120. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: A double-blind trial
121. Cholera
122. Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea
123. Failure of newer 13 Β-1actam antibiotics for murine Yersinia enterocolitica Infection
124. Vitek system antimicrobial susceptibility testing of 01, 0139, and non-01 Vibrio cholerae
125. Practical guidelines for the treatment of cholera
126. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea
127. Why treatment centers failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire
128. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998
129. Escherichia coil O157:H7 infections in humans
130. Escherichia caff O157:H7: Clinical, diagnostic, and Epidemiologic aspects of human infection
131. Approach to the patient with acute bloody diarrhea
132. Diabetes mellitus-newly described risk factor for infection from Salmonella enteridis
133. Enteric Escherichia coli infections
134. Antibiotics in the treatment of gestroenteritis caused by enteropothogenic Escherichia coli
135. Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa
136. High-level resistance to ciprofloxacin in Escherichia coli
137. Increasing spectrum of resistance in multiresistant Salmonella typhimurium
138. Ciprofloxacin-resistant Salmonella typhi and treatment failure
139. Single dose ciprofloxacin in cholera
140. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis
141. Investigation of multiresistant Salmonella serotype typhimurium DT 104 infections linked to raw-milk cheese in Washington state
142. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever
143. Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin 1
144. Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus
145. Successful heatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus
146. Comparison of vancomycin, telcoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea
147. Empiric treatment of acute diarrheal disease with norfloxacin: A randomized, placebo-controlled study
148. The risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
149. Quiynolone antibiotics induce shiga toxin-encoding bacteriophages, toxin poduction, and death in mice